FILTER

FILTERED INTERVIEW RESULTS

Ted Moses O.Q

President, SAENCAT
The Secretariat promotes sustainable relations and socio-economic alliances across the region to foster harmonious development.

Steve Dixon

CEO, STRACON
STRACON provides mining services in Peru and Latin America, covering all the stages of a mining project.

John Downing & Ian Mitchell

CEO & GENERAL MANAGER, DOWNING TEAL
Formed in 1966, Downing Teal is a Perth-based employment services firm.

John Black

CEO, REGULUS RESOURCES
Regulus Resources announces encouraging results following the completion of its Phase 1 drilling program in late 2018.

Michael Gribbons

VICE PRESIDENT OF SALES AND MARKETING AND CO-FOUNDER, MAESTRO DIGITAL MINE
Maestro Digital Mine manufacturers IoT and control instrumentation for the optimization of underground mine ventilation and underground digital networks.

Dean McPherson

HEAD OF GLOBAL MINING, TMX GROUP
Toronto Stock Exchange (TSX), the largest stock market for mining companies globally, is committed to exploring the growing opportunities in Latin America’s mining industry.

Alain Carrier, Carl Pelletier & Denis Gourde

CO-FOUNDER, CO-FOUNDER & VP, INNOVEXPLO
InnovExplo is an independent consulting firm in geology, mining engineering and sustainable development.

Adriaan Bakker

PRESIDENT & CEO, VANADIUMCORP
VanadiumCorp aims to become a leading supplier of battery materials and specialty metals for the emerging energy storage market.

Carlos Gálvez

PRESIDENT OF THE ORGANIZING COMMITTEE, PERUMIN
The president of PERUMIN discusses key issues facing the country’s mining industry as the event prepares for its 34th annual gathering.

Shawn Ryan, & David D’Onofrio

CTO & CEO, WHITE GOLD CORP.
White Gold Corp. is the largest landholder in the Yukon's White Gold District with 13 projects on 37 properties.

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

United States Life Sciences 2025 - Digital Interactive

Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.

PARTNER EVENTS